David B. Camp, Co-Founder & Director
David Camp has extensive experience in the medical device field, with a particular focus on cardiovascular device markets. He has over 30 years’ experience in areas that include new product launch, sales and marketing, and direct distribution to cardiologists and cardiovascular surgeons for angioplasty and cardiac rhythm management devices. David has a successful track record for introducing new technology, developing successful distribution networks, and for establishing loyal surgeon user networks. His background includes Smith Kline, U.S. Surgical, American Edwards Corp. (AME), SciMed Life Systems (purchased by Boston Scientific), Medtronic, and St. Jude Medical. He was one of the original sales and marketing team responsible for the launch of the angiographic division of AME. He was also one of the original four sales representatives hired in 1987 to launch a new angioplasty technology nationwide for SciMed Life Systems. During his nine-year tenure with SciMed, his team was responsible for growing sales from zero to over $350 Million.
Robert G. Matheny, MD, Co-Founder, Director
Chief Scientific Officer & Chief Medical Officer
Dr. Robert Matheny is a cardiothoracic surgeon and distinguished pioneer of minimally invasive cardiac surgical procedures. Dr. Matheny did his undergraduate studies at the University of Oklahoma and Baylor University completing his MD at the University of Texas, performed his surgical residency at Texas A&M University, and completed his cardiothoracic fellowship at Ohio State University. He has been certified by the American Board of Surgery and the American Board of Thoracic Surgery. Dr. Matheny has worked with a number of medical device companies as a consultant in off-pump heart surgery, atrial fibrillation, robotics, and ventricular support devices, including CardioThoracic Systems, Medtronic, Embolex, Amed Systems, Guidant, AFx and Corazon. He has a long list of published articles and chapters and holds patents for many medical devices. Dr. Matheny is the Vice President of Research and Development as well as Scientific Advisory Board Director for CorMatrix and has worked with Extracellular Matrix materials for cardiovascular applications since 1993. He is co-inventor on several of the Purdue ECM patents.
John C. Thomas, Jr., Chief Financial Officer & Secretary
John Thomas has served as the CFO and Secretary of the Company since inception. Over the past 30 years, Mr. Thomas has served as the CFO of numerous startup companies and helped them raise initial capital from the initial financing up to their initial public offering. Some of these companies are still private and some have become public entities. The companies in the health care industry that have gone public while Mr. Thomas was the CFO include CytRx Corporation (1986 – 1990), Medicis Pharmaceutical Corporation (1988 – 1991), EntreMed, Inc. (1991 – 1997), DARA BioSciences, Inc. (1998 – 2009), and MiMedx, Inc. (2006 – 2009). Mr. Thomas is also the CFO of Motion Reality, Inc., a privately-held company with proprietary software that captures and analyzes motion data and has been since 1991. Mr. Thomas is a board member of Motion Reality, Inc., QLT, Inc., a publicly traded biotechnology company, NantKwest, Inc., a publicly traded immunotherapy company focused on cancer, and Medovex, Inc., a publicly traded biotechnology company. Mr. Thomas is a graduate of the McIntire School of Commerce of the University of Virginia and is a certified public accountant.
Blane Crutchfield – Director
Blane has served as a member of the Company’s Board of Directors since inception. He is a partner at Hand Arendall LLC, a regional law firm headquartered in Alabama. Blane has been in private practice for 29 years and has served as counsel to a number of small and medium sized companies. Blane and his firm have represented the Company since its inception.